Skip to Main Content

Paper Details

CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
PLoS One
21
2019
Author NameAffiliation
Mee-Yon ChoYonsei University Wonju College of Medicine
  • 1 - 1

Datasets

Release 1.2